Table 3.

Predictors of definite myocardial functional deterioration and ΔEcc after adjustment for baseline Ecc.

	Definite Deterioration Group			ΔEcc
Variables	OR	95% CI	P	B	95% CI	P
Age, per y	1.01	0.10, 1.03	0.38	0.005	−0.02, 0.03	0.65
Male	1.63	1.06, 2.52	0.03	0.70	0.32, 1.08	<0.001
Body mass index, per kg/m2	1.02	0.97, 1.06	0.52	0.003	−0.04, 0.04	0.90
Systolic blood pressure, per mmHg	1.01	0.99, 1.02	0.12	0.002	−0.008, 0.01	0.74
Diastolic blood pressure, per mmHg	1.02	0.99, 1.04	0.18	0.02	0.005, 0.04	0.01
Hypertension	1.30	0.84, 2.00	0.24	0.04	−0.34, 0.42	0.84
Diabetes	1.41	0.73, 2.72	0.30	0.31	−0.27, 0.89	0.29
Current smoking	2.11	1.52, 2.91	<0.001	1.35	0.73, 1.97	<0.001
Statin use	1.32	0.77, 2.26	0.32	0.20	−0.29, 0.69	0.42
Aspirin use	1.42	0.86, 2.35	0.17	0.07	−0.38, 0.51	0.77
Beta-blocker use	1.52	0.79, 2.93	0.21	0.26	−0.38, 0.89	0.43
ACE inhibitor use	0.76	0.45, 1.80	0.76	−0.25	−0.81, 0.31	0.38
ARB use	1.54	0.66, 3.62	0.32	0.21	−0.60, 1.03	0.61
Urine albumin/creatinine, per mg/g	1.00	0.99, 1.01	0.51	−0.001	−0.006, 0.003	0.57
LV mass index, per 1 g/m2	1.02	1.01, 1.04	0.002	0.03	−0.87, −0.72	<0.001
LV ejection fraction, per 1%	1.00	0.95, 1.02	0.46	−0.05	−0.08, −0.03	<0.001
Presence of coronary calcium	1.32	0.86, 2.03	0.21	0.21	−0.17, 0.58	0.28
CRP, per 1mg/dL	1.07	1.04, 1.11	<0.001	0.06	0.03, 0.097	0.001

See abbreviations in table 2